High-dose Vitamin D to prevent bone loss in older prostate cancer patients on hormone therapy
Official title: High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Funded at University of Rochester · NIH-10983309 · Data updated 2026-11-12
This study is looking at whether taking high doses of vitamin D can help older men with prostate cancer who are on hormone therapy keep their bones strong and improve their strength and balance, making it less likely for them to have fractures or falls.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | December 17, 2021 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $639,100 |
| NIH project number | 5R01CA258349-04 |
| Project ID | NIH-10983309 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older prostate cancer patients aged 65 and above who are currently undergoing androgen deprivation therapy.
✕Less likely to help
Patients who are not undergoing androgen deprivation therapy or are younger than 65 years old may not benefit from this research.
What this research studies
This research investigates the effects of high-dose vitamin D supplementation on bone health in older prostate cancer patients undergoing androgen deprivation therapy (ADT). ADT can lead to significant bone mineral density loss and muscle mass reduction, increasing the risk of fractures and falls. The study aims to determine if administering high doses of vitamin D can mitigate these adverse effects, improve bone density, and enhance overall physical strength and balance. Participants will receive vitamin D supplementation and be monitored for changes in bone health and muscle function.
Why it matters
Potential benefit: If successful, this research could help prevent bone loss and improve the quality of life for older prostate cancer patients receiving hormone therapy.
How similar studies have gone: Previous research has shown that high-dose vitamin D can effectively improve bone density in other populations, suggesting potential success for this approach in prostate cancer patients.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Peppone, Luke Joseph — University of Rochester
- Study coordinator: Peppone, Luke Joseph
Related research
Other NIH-funded projects on the same topics.
-
High-dose vitamin D for bone and muscle loss in older men on hormone therapy
Older men on androgen-deprivation therapy for prostate cancer will receive higher-dose vitamin D to help protect their bones and muscles.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Effects of ADT on motivation and emotion in prostate cancer patients
This project looks at how androgen deprivation therapy may affect motivation and mood over time in men with prostate cancer.
-
Causal Protein Markers to Understand and Predict Prostate Cancer Risk in Africans and Europeans
A cancer research project looking at proteins linked to prostate cancer to better understand why it happens and how risk differs between African and European populations.
-
Ethical multimodal AI platform to improve prostate cancer detection with ultrasound
A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.
-
How HIV and HIV meds affect jaw bone and teeth
This project looks at how HIV, its treatment, and immune changes may cause jawbone and tooth loss in people living with HIV.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.